Literature DB >> 355185

Pineal gland involvement in retina-induced experimental allergic uveitis.

C M Kalsow, W B Wacker.   

Abstract

A form of experimental allergic uveitis (EAU) can be elicited in guinea pigs by injection of an extract of homologous retina homogenate (S preparation). These guinea pigs exhibit clinical and histological ocular disease as well as cellular and humoral immune responses to S preparation. Recent studies have shown an immunofluorescent crossreactivity of the sera of these animals (anti-S) with retinal photoreceptors and pinealocytes. The experiments presented in this paper demonstrate pineal gland involvement during the course of S preparation-induced EAU. There is lymphocytic infiltration of the pineal gland, with corresponding loss of antigen reactivity and some disturbance in cell structure. Pineal gland infiltrate can be seen before observable retinal involvement. Similarity of the reactive substances in retinal photoreceptors and pinealocytes is demonstrated by a reaction of identity in immunodiffusion studies and similar mobilities in immunoelectrophoretic studies of S preparation and pineal gland extract with anti-S serum. The relationship of the retinal and pineal substances to each other, as well as their role in disease development in the animal model and possibly in human uveitides, are discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 355185

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  12 in total

1.  Ultrastructural pathology of the 'barrier sites' in experimental autoimmune uveitis and experimental autoimmune pinealitis.

Authors:  H S Dua; A McKinnon; P G McMenamin; J V Forrester
Journal:  Br J Ophthalmol       Date:  1991-07       Impact factor: 4.638

2.  Two alternatively spliced forms of the cGMP-gated channel alpha-subunit from cone photoreceptor are expressed in the chick pineal organ.

Authors:  W Bönigk; F Müller; R Middendorff; I Weyand; U B Kaupp
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

3.  The effect of retinal S-antigen-specific monoclonal antibody therapy on experimental autoimmune uveoretinitis (EAU) and experimental autoimmune pinealitis (EAP).

Authors:  H S Dua; H F Sewell; J V Forrester
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

4.  Immunocytochemical and electron-microscopic characterization of macrophage/microglia cells and expression of class II major histocompatibility complex in the pineal gland of the rat.

Authors:  E B Pedersen; L M Fox; A J Castro; J A McNulty
Journal:  Cell Tissue Res       Date:  1993-05       Impact factor: 5.249

5.  Trilateral retinoblastoma: A systematic review of 211 cases.

Authors:  Ryuya Yamanaka; Azusa Hayano; Yasuo Takashima
Journal:  Neurosurg Rev       Date:  2017-08-16       Impact factor: 3.042

6.  An 18-mer peptide derived from the retinal S antigen induces uveitis and pinealitis in primates.

Authors:  S Hirose; V K Singh; L A Donoso; T Shinohara; S Kotake; T Tanaka; T Kuwabara; K Yamaki; I Gery; R B Nussenblatt
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

7.  Effects of continuous light exposure on the rat retina and pineal gland.

Authors:  M Mochizuki; T Kuwabara; I Gery
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

8.  Elevated prolactin levels in human aqueous humor of patients with anterior uveitis.

Authors:  U Pleyer; D Gupta; E G Weidle; W Lisch; M Zierhut; H J Thiel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

9.  Primary and secondary structure of bovine retinal S antigen (48-kDa protein).

Authors:  T Shinohara; B Dietzschold; C M Craft; G Wistow; J J Early; L A Donoso; J Horwitz; R Tao
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

10.  Pinealitis accompanying equine recurrent uveitis.

Authors:  C M Kalsow; A E Dwyer; A W Smith; T P Nifong
Journal:  Br J Ophthalmol       Date:  1993-01       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.